WASHINGTON (Reuters) - Taro Pharmaceutical agreed to pay more than $200 million to settle allegations that it conspired to fix the prices of generic drugs, the Justice Department said on Thursday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback